by MDB Manager | Mar 5, 2025 | Press Releases
China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China – underlining its dominant position in next-generation AI infrastructure Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) — Today,...
by MDB Manager | Feb 19, 2025 | Press Releases
Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) — eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced that CEO Michael Heltzen...
by MDB Manager | Feb 12, 2025 | Press Releases
Rebranding Invizyne Technologies, Inc to eXoZymes Inc. Changing NASDAQ ticker from IZTC to EXOZ Introducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE NEWSWIRE) — Today, Invizyne Technologies, Inc....
by Staff | Feb 10, 2025 | Press Releases
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025. Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) (“Invizyne”), a leading designer of cell-free, enzyme-based biomanufacturing...
by Staff | Jan 29, 2025 | Press Releases
SANTA CLARA, Calif.–(BUSINESS WIRE)– HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to the U.S. Food and...
by Staff | Dec 16, 2024 | Press Releases
First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the credit card-sized device with them at all times, ready to record an ECG...
Recent Comments